JUPITER Not Enough To Expand CRP Testing Indication, Experts Say
This article was originally published in The Gray Sheet
Executive Summary
Experts are not ready to call for an expansion of high-sensitivity C-reactive protein (hsCRP) testing, even though new trial results show elevated CRP testing can identify patients with low cholesterol who might benefit from statin drugs